KIERAN GALLAHUE
CIK 1308428 · Executive Chairman · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$21.80M
Companies
7
Total Filings
109
Lifetime Open-Market Net
-$28.19M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVST | Director | 54,010 | $28.38 | $1.53M | $0 | 8 | 2026-05-21 |
| EW | Director | 82,907 | $92.17 | $7.64M | -$3.32M | 17 | 2026-05-08 |
| Intersect ENT, Inc. (XENT) Delisted | Executive Chairman | 0 | $28.24 | $0 | $101.1K | 12 | 2022-05-16 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | Director | 0 | $99.99 | $0 | $0 | 5 | 2022-03-11 |
| CAREFUSION Corp (CFN) Delisted | Chairman and CEO | 740,251 | — | — | -$2.03M | 14 | 2015-03-13 |
| Volcano Corp (VOLC) Delisted | Director | 6,027 | — | — | $0 | 10 | 2013-05-17 |
| RMD | Chief Executive Officer | 56,921 | $221.87 | $12.63M | -$22.95M | 40 | 2011-01-07 |
Recent Filings · Page 5 of 11
109 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-05-19 | EW | Grant (A) | +1,521 | $0 | EDGAR |
| 2015-04-10 | Intersect ENT, Inc. (XENT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-19 | — | Mixed | −740,251 | $0 | |
| 2015-03-13 | CAREFUSION Corp (CFN) Delisted | Mixed | +385,470 | -$24.82M | EDGAR |
| 2015-02-23 | EW | Grant (A) | — | $0 | EDGAR |
| 2015-02-19 | — | Disp (D) | −9,738 | -$175.3K | |
| 2014-12-19 | CAREFUSION Corp (CFN) Delisted | Gift (G) | −4,250 | $0 | EDGAR |
| 2014-08-19 | CAREFUSION Corp (CFN) Delisted | Mixed | +31,442 | -$1.51M | EDGAR |
| 2014-08-07 | CAREFUSION Corp (CFN) Delisted | Mixed | +22,467 | -$1.05M | EDGAR |
| 2014-02-18 | CAREFUSION Corp (CFN) Delisted | Mixed | +117,970 | -$5.27M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.